Aura™ Biosciences is pioneering the development of nano-delivered drugs through its proprietary Nanosmart™ platform. Nanosmart solves critical issues in drug delivery by encapsulating therapies within protein nanoparticles.

Designed to mimic viral structures, these nanoparticles are engineered for precise targeting, immune system evasion, and efficient cellular uptake. With uniform structures to provide reproducible drug loading, Nanosmart particles are also designed for scalable manufacturing.

Aura’s initial focus is on applying Nanosmart to the delivery of small molecules and siRNA in oncology. Nanosmart-delivered drugs are designed to be more effective and better tolerated, improving survival and enabling more patients to be treated.

More >>